Mechanisms of Resistance to Photodynamic Therapy
Open accessThe DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
Abstract
Photodynamic therapy (PDT) involves the administration of a photosensitizer (PS) followed by illumination with visible light, leading to generation of reactive oxygen species. The mechanisms of resistance to PDT ascribed to the PS may be shared with the general mechanisms of drug resistance, and are related to altered drug uptake and efflux rates or altered intracellular trafficking. As a second step, an increased inactivation of oxygen reactive species is also associated to PDT resistance via antioxidant detoxifying enzymes and activation of heat shock proteins. Induction of stress response genes also occurs after PDT, resulting in modulation of proliferation, cell detachment and inducing survival pathways among other multiple extracellular signalling events. In addition, an increased repair of induced damage to proteins, membranes and occasionally to DNA may happen. PDT-induced tissue hypoxia as a result of vascular damage and photochemical oxygen consumption may also contribute to the appearance of resistant cells. The structure of the PS is believed to be a key point in the development of resistance, being probably related to its particular subcellular localization. Although most of the features have already been described for chemoresistance, in many cases, no cross-resistance between PDT and chemotherapy has been reported. These findings are in line with the enhancement of PDT efficacy by combination with chemotherapy. The study of cross resistance in cells with developed resistance against a particular PS challenged against other PS is also highly complex and comprises different mechanisms. In this review we will classify the different features observed in PDT resistance, leading to a comparison with the mechanisms most commonly found in chemo resistant cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–228 of 228
Datta, S. N., Allman, R., Loh, C. S., Mason, M. D., & Matthews, P. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.384 · Cited by 32
Bid Is Required in NPe6‐PDT‐induced Apoptosis
Wan, Q., Liu, L., Xing, D., & Chen, Q. (2007) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2007.00248.x · Cited by 32
Verwanger, T., Šanović, R., Aberger, F., Frischauf, A., & Krammer, B. E. (2002) · International Journal of Oncology · doi:10.3892/ijo.21.6.1353 · Cited by 31
Yeung, B. H. Y., Wong, K. Y., Lin, M. C., Wong, C. K. C., Mashima, T., TSURUO, T., & Wong, A. S. T. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604477 · Cited by 31
Adigbli, D. K., Wilson, D. G. G., Farooqui, N., Sousi, E., Risley, P., Taylor, I., MacRobert, A. J., & Loizidou, M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603895 · Cited by 29
Enhancement of aminolevulinic acid based photodynamic therapy by adriamycin
Casas, A. G., Fukuda, H., Riley, P. A., & Batlle, A. M. D. C. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00338-8 · Cited by 27
Self-citationBioreductive agents: a clinical update.
Boyer, M. J. (1997) · PubMed · Cited by 26
Merlin, J., Gautier, H., Barberi‐Heyob, M., Teiten, M.-H., & Guillemin, F. H. (2003) · International Journal of Oncology · doi:10.3892/ijo.22.4.733 · Cited by 26
Chu, E. S. M., Yow, C. M. N., Shi, M. R., & Ho, R. J. Y. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.06.860 · Cited by 25
Modification of chemotherapeutic effects on L1210 cells using hematoporphyrin and light.
Creekmore, S. P., & Zaharko, D. S. (1983) · PubMed · Cited by 22
Adams, K. M., Rainbow, A. J., Wilson, B. C., et al. (1999) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/s1011-1344(99)00047-0 · Cited by 22
Venosa, G. M. D., Perotti, C., Fukuda, H., Batlle, A. M. D. C., & Casas, A. G. (2005) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2005.05.001 · Cited by 20
Self-citationOyan, A. M., Ånensen, N., Bø, T. H., Stordrange, L., Jonassen, I., Bruserud, Ø., Kalland, K., & Gjertsen, B. T. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-77 · Cited by 19
Rodríguez, L., Venosa, G. M. D., Batlle, A. M. D. C., MacRobert, A. J., & Casas, A. G. (2007) · Photochemical & Photobiological Sciences · doi:10.1039/b704235c · Cited by 19
Self-citationNakagawa, H., Matsumiya, T., Sakaki, H., Imaizumi, T., Kubota, K., Kusumi, A., Kobayashi, W., & Kimura, H. (2007) · Oral Oncology · doi:10.1016/j.oraloncology.2006.03.020 · Cited by 19
Zaręba, M., Niziolek, M., Korytowski, W., & Girotti, A. W. (2004) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.11.007 · Cited by 17
Mouse mammary carcinoma porphobilinogenase and hydroxymethylbilane synthetase
Navone, N. M., Polo, C. F., Frisardi, A. L., & Batlle, A. M. D. C. (1991) · Comparative Biochemistry and Physiology Part B Comparative Biochemistry · doi:10.1016/0305-0491(91)90309-2 · Cited by 16
Self-citationZacal, N., & Rainbow, A. J. (2007) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2007.00078.x · Cited by 15
Mechanistic studies on δ-aminolevulinic acid uptake and efflux in a mammary adenocarcinoma cell line
García, S. C., Casas, A. G., Perotti, C., Batlle, A. M. D. C., & Moretti, M. B. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601066 · Cited by 14
Self-citationApoptosis associated with esophageal adenocarcinoma: influence of photodynamic therapy
McGarrity, T. J., Peiffer, L. P., Granville, D. J., Carthy, C. M., Levy, J. G., Khandelwal, M., & Hunt, D. W. C. (2001) · Cancer Letters · doi:10.1016/s0304-3835(00)00663-7 · Cited by 13
Ha‐Ras sensitizes transformed mouse skin cells to Anisomycin‐induced apoptosis
Santibanez, J. F., & Hurtado, C. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.10.025 · Cited by 12
Increased BNip3 and decreased mutant p53 in cisplatin-sensitive PDT-resistant HT29 cells
Zacal, N., Espiritu, M., Singh, G., & Rainbow, A. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.213 · Cited by 12
Nitric Oxide Control of MYCN Expression and Multi Drug Resistance Genes in Tumours of Neural Origin
Porro, A., Crochemore, C., Cambuli, F., Iraci, N., Contestabile, A., & Perini, G. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210790232112 · Cited by 12
Reyal, J. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.09.002 · Cited by 9
Potentiation of the 5-aminolevulinic acid-based photodynamic therapy with cyclophosphamide.
Casas, A. G., Fukuda, H., & Batlle, A. M. (1998) · PubMed · Cited by 9
Self-citationNo cross-resistance between ALA-mediated photodynamic therapy and nitric oxide
Venosa, G. M. D., Casas, A. G., Fukuda, H., Perotti, C., & Batlle, A. M. D. C. (2005) · Nitric Oxide · doi:10.1016/j.niox.2005.04.010 · Cited by 7
Self-citationThe expression of BCRP/ABCG2 causes resistance to Photofrin®-PDT
Tsunoda, Y., Usuda, J., Imai, K., Kubota, M., Maehara, S., Ohtani, K., Inoue, T., Hirata, T., Ichinose, S., Ishizumi, T., et al. (2007) · Nippon Laser Igakkaishi · doi:10.2530/jslsm.28.355 · Cited by 6
Apoptosis‐accommodating Effect of Nitric Oxide in Photodynamically Stressed Tumor Cells
Niziolek, M., Pilat, A. K., Korytowski, W., & Girotti, A. W. (2010) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2010.00712.x · Cited by 6
Cited by
Clinical development and potential of photothermal and photodynamic therapies for cancer
Li, X., Lovell, J. F., Yoon, J., & Chen, X. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0410-2 · Cited by 3,456
Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions
Van Straten, D., Mashayekhi, V., De Bruijn, H., Oliveira, S., & Robinson, D. (2017) · Cancers · doi:10.3390/cancers9020019 · Cited by 1,012
Dai, Y., Xu, C., Sun, X., & Chen, X. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00592f · Cited by 931
Nanotechnology-Based Drug Delivery Systems for Photodynamic Therapy of Cancer: A Review
Calixto, G., Bernegossi, J., De Freitas, L., Fontana, C., & Chorilli, M. (2016) · Molecules · doi:10.3390/molecules21030342 · Cited by 538
Overcoming barriers in photodynamic therapy harnessing nano-formulation strategies
Xie, J., Wang, Y., Choi, W., Jangili, P., Ge, Y., Xu, Y., Kang, J., Liu, L., Zhang, B., Xie, Z., et al. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01370f · Cited by 522
Metadata
- Authors
- Casas, A., Di Venosa, G., Hasan, T., & Batlle, A.
- Venue
- Current Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2011-06-01
- Volume
- 18
- Issue
- 16
- Pages
- 2486-2515
- ISSN
- 0929-8673 (ISSN-L)
- OpenAlex
- W2078225696
- Cited by
- 322
- References
- 228
- FWCI
- 8.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.